CNADF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
4.51M
HLN
Price
$9.80
Change
+$0.12 (+1.24%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
43.75B
62 days until earnings call
Interact to see
Advertisement

CNADF vs HLN

Header iconCNADF vs HLN Comparison
Open Charts CNADF vs HLNBanner chart's image
CANADABIS CAP
Price$0.06
Change-$0.00 (-0.00%)
Volume$6K
Capitalization4.51M
Haleon
Price$9.80
Change+$0.12 (+1.24%)
Volume$99.73K
Capitalization43.75B
CNADF vs HLN Comparison Chart in %
Loading...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNADF vs. HLN commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNADF is a Hold and HLN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (CNADF: $0.06 vs. HLN: $9.69)
Brand notoriety: CNADF and HLN are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CNADF: 100% vs. HLN: 62%
Market capitalization -- CNADF: $4.5M vs. HLN: $43.75B
CNADF [@Pharmaceuticals: Generic] is valued at $4.5M. HLN’s [@Pharmaceuticals: Generic] market capitalization is $43.75B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNADF’s FA Score shows that 0 FA rating(s) are green whileHLN’s FA Score has 1 green FA rating(s).

  • CNADF’s FA Score: 0 green, 5 red.
  • HLN’s FA Score: 1 green, 4 red.
According to our system of comparison, both CNADF and HLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 5 TA indicator(s) are bullish.

  • HLN’s TA Score: 5 bullish, 3 bearish.

Price Growth

CNADF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while HLN (@Pharmaceuticals: Generic) price change was -1.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.25%. For the same industry, the average monthly price growth was +68.20%, and the average quarterly price growth was +81.63%.

Reported Earning Dates

HLN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($43.7B) has a higher market cap than CNADF($4.51M). HLN has higher P/E ratio than CNADF: HLN (21.73) vs CNADF (11.57). CNADF YTD gains are higher at: 78.571 vs. HLN (3.358). HLN has higher annual earnings (EBITDA): 2.71B vs. CNADF (1.54M). HLN has more cash in the bank: 676M vs. CNADF (948K). CNADF has less debt than HLN: CNADF (9.18M) vs HLN (8.45B). HLN has higher revenues than CNADF: HLN (11B) vs CNADF (17.2M).
CNADFHLNCNADF / HLN
Capitalization4.51M43.7B0%
EBITDA1.54M2.71B0%
Gain YTD78.5713.3582,340%
P/E Ratio11.5721.7353%
Revenue17.2M11B0%
Total Cash948K676M0%
Total Debt9.18M8.45B0%
TECHNICAL ANALYSIS
Technical Analysis
CNADFHLN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
56%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
55%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
59%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
30%
Bearish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
35%
Bearish Trend 2 days ago
41%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
57%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
53%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
36%
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NCTY9.340.69
+7.98%
The9 Limited
CRDO131.829.09
+7.41%
Credo Technology Group Holding Ltd
ABL6.930.02
+0.29%
Abacus Global Management Inc
GENI12.830.01
+0.08%
Genius Sports Limited
YAAS0.32-0.01
-3.17%
Youxin Technology Ltd

CNADF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with BJTRF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then BJTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
BJTRF - CNADF
61%
Loosely correlated
N/A
STEK - CNADF
26%
Poorly correlated
-4.07%
PLSH - CNADF
21%
Poorly correlated
N/A
HLN - CNADF
15%
Poorly correlated
-0.21%
PLNH - CNADF
5%
Poorly correlated
-2.41%
More

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
-0.21%
HLNCF - HLN
49%
Loosely correlated
+0.10%
TAK - HLN
43%
Loosely correlated
+0.74%
ZTS - HLN
40%
Loosely correlated
-0.37%
ALKS - HLN
30%
Poorly correlated
-1.09%
PRGO - HLN
29%
Poorly correlated
-0.54%
More